JLB Vol 112 Issue 4 TOC |
ISSUE INFORMATION Free Access
Issue InformationPages: 577-583 | First Published: 30 September 2022 LETTER TO THE EDITOR Neutrophil serine proteases in vitro: How much and why? Eric K. Patterson, Douglas D. Fraser, Gediminas Cepinskas
Pages: 585-586 | First Published: 08 September 2022 EDITORIAL Open Access
Scylla, Charybdis, and navigating antimicrobial action in the neutrophil phagosome William M. Nauseef
Pages: 587-589 | First Published: 04 August 2022 SPOTLIGHT ON LEADING EDGE RESEARCH Open Access
Oxidation of bacillithiol during killing of Staphylococcus aureus USA300 inside neutrophil phagosomes Louisa V Ashby, Reuben Springer, Vu Van Loi, Haike Antelmann, Mark B Hampton, Anthony J Kettle, Nina Dickerhof
Pages: 591-605 | First Published: 27 May 2022 REVIEW Pediatric inborn errors of immunity causing hemophagocytic lymphohistiocytosis: Case report and review of the literature María Soledad Caldirola, Andrea Gómez Raccio, Daniela Di Giovanni, María Isabel Gaillard, María Victoria Preciado
Pages: 607-615 | First Published: 28 July 2022 CELL DEVELOPMENT, DIFFERENTIATION AND TRAFFICKING Fatty acids secreted from head and neck cancer induce M2‐like Macrophages Marwah M Albakri, Stanley Ching-Cheng Huang, Hammad N Tashkandi, Scott F Sieg
Pages: 617-628 | First Published: 25 February 2022 Intrathymic SIRPa cDC subsets organization in normal and stress conditions reveal another level of cDCs heterogeneity Victoria Michaels Lopez, Agnès Legrand, Emmanuel Tejerina, Jérome Megret, Chantal Bordin, Véronique Quellec, Sophie Ezine
Pages: 629-639 | First Published: 27 February 2022 ETS2 repressor factor (ERF) is involved in T lymphocyte maturation acting as regulator of thymocyte lineage commitment Spyridoula Tsiomita, Effrosyni Maria Liveri, Panagiota Vardaka, Angeliki Vogiatzi, Argyris Skiadaresis, George Saridis, Ioannis Tsigkas, Theologos M. Michaelidis, George Mavrothalassitis, George Thyphronitis
Pages: 641-657 | First Published: 08 March 2022 Open Access
The SC cell line as an in vitro model of human monocytes Amira Duweb, Ann-Kathrin Gaiser, Isabel Stiltz, Menna El Gaafary, Thomas Simmet, Tatiana Syrovets
Pages: 659-668 | First Published: 31 March 2022 RECEPTORS, SIGNAL TRANSDUCTION AND GENES Gab2 promotes acute myeloid leukemia growth and migration through the SHP2‐Erk‐CREB signaling pathway Rui Gong, Haoying Li, Yaqi Liu, Yanyan Wang, Lu Ge, Liuzhi Shi, Guang Wu, Jianxin Lyu, Haihua Gu, Licai He
Pages: 669-677 | First Published: 24 March 2022 INFLAMMATION, EXTRACELLULAR MEDIATORS AND EFFECTOR MOLECULES Open Access
Cytokine responses to LPS in reprogrammed monocytes are associated with the transcription factor PU.1 Kedeye Tuerxun, Kristine Midtbö, Eva Särndahl, Egor Vorontsov, Roger Karlsson, Alexander Persson, Robert Kruse, Daniel Eklund, the X-HiDE Consortium
Pages: 679-692 | First Published: 13 March 2022 Erythrocyte‐derived extracellular vesicles aggravate inflammation by promoting the proinflammatory macrophage phenotype through TLR4–MyD88–NF‐κB–MAPK pathway Yuhan Gao, Haiqiang Jin, Hui Tan, Xiaodong Cai, Yongan Sun
Pages: 693-706 | First Published: 12 April 2022 Neutrophil‐derived extracellular vesicles promote feed‐forward inflammasome signaling in cystic fibrosis airways Osric A. Forrest, Brian Dobosh, Sarah A. Ingersoll, Sanjana Rao, Alexander Rojas, Julie Laval, Jessica A. Alvarez, Milton R. Brown, Vin Tangpricha, Rabindra Tirouvanziam
Pages: 707-716 | First Published: 16 February 2022 HOST DEFENSE AND PATHOPHYSIOLOGY Human mucosal Vα7.2+CD161hi T cell distribution at physiologic state and in Helicobacter pylori infection Norasate Boonpattanaporn, Thidarat Kongkaew, Panjana Sengprasert, Michael N.T. Souter, Narisorn Lakananurak, Rungsun Rerknimitr, Alexandra J. Corbett, Rangsima Reantragoon
Pages: 717-732 | First Published: 15 June 2022 Open Access
Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection Livio Azzoni, Leila B. Giron, Surya Vadrevu, Ling Zhao, Linden Lalley-Chareczko, Emily Hiserodt, Matthew Fair, Kenneth Lynn, Stacey Trooskin, Karam Mounzer, Mohamed Abdel-Mohsen, Luis J. Montaner
Pages: 733-744 | First Published: 02 August 2022 TRANSLATIONAL AND CLINICAL IMMUNOLOGY Landscape of T Cells in NK‐AML(M4/M5) Revealed by Single‐Cell Sequencing Wenqi Wu, Xiaolin Liang, Huiqun Li, Xiaoke Huang, Chengyao Wan, Qiongni Xie, Zhenfang Liu
Pages: 745-758 | First Published: 08 March 2022 TECHNICAL ADVANCE Robust engraftment of fetal nonhuman primate CD34‐positive cells in immune‐deficient mice Christopher J. Little, William J. Haynes, Liupei Huang, Cross M. Daffada, Bryce K. Wolfe, Elizabeth Perrin, John A. Simpson, Jenna A. Kropp Schmidt, Hayly M. Hinkle, Logan T. Keding, Ryan T. Behrens, David T. Evans, Dixon B. Kaufman, James A. Thomson, Thaddeus G. Golos, Matthew E. Brown
Pages: 759-769 | First Published: 30 March 2022 Meeting: Targeted Science Issue - The 7th Macau Symposium on Biomedical Sciences and the South China Symposium on Frontiers in Immunology and Disease Guest Editors: Jiahong Lu, Huanhuan He, Qi Zhao, and Xiang Lin REVIEWS Roles of the nucleus in leukocyte migration Yutao Li, Mengqi Chen, Wakam Chang
Pages: 771-783 | First Published: 02 August 2022 R4 RGS proteins as fine tuners of immature and mature hematopoietic cell trafficking Kathy Yuen Yee Chan, Po Yee Chung, Chi Zhang, Ellen Ngar Yun Poon, Alex Wing Kwan Leung, Kam Tong Leung
Pages: 785-797 | First Published: 13 June 2022 Structures, functions, and inhibitors of LUBAC and its related diseases Shuo Ning, Lingling Luo, Beiming Yu, Dina Mai, Feng Wang
Pages: 799-811 | First Published: 09 March 2022 Immunotherapy targeting mesothelin in acute myeloid leukemia Qingguang Wang, Rui Gong
Pages: 813-821 | First Published: 10 August 2022 2022 update on the scientific premise and clinical trials for IL‐15 agonists as cancer immunotherapy Yingjun Peng, Shengyu Fu, Qi Zhao
Pages: 823-834 | First Published: 26 May 2022 PRIMARY RESEARCH Synthesis and identification of lithocholic acid 3‐sulfate as RORγt ligand to inhibit Th17 cell differentiation Riping Xiao, Kawai Lei, Hioha Kuok, Wende Deng, Yuxin Zhuang, Yanqing Tang, Zhengyang Guo, Hongyan Qin, Li-Ping Bai, Ting Li
Pages: 835-843 | First Published: 21 February 2022 Graphical Abstract Bile acid (BA) synthesis and cholesterol clearance pathway. Regulation of BA synthesis by feedback mechanism and BA transport through enterohepatic circulation. In the liver, cholesterol is metabolized to primary BAs (CA, CDCA) via primary pathway and alternative pathway, and conjugated with glycine or taurine, converted to TCA, GCA, GCDCA, and TCDCA. Primary BAs are transported to intestine via biliary excretion, and converted to secondary BAs (DCA, UDCA, LCA) by gut commensal bacteria, and conjugated with glycine or taurine, converted to GDCA, TUDCA, GUDCA, and GLCA. As the most common secondary BA, LCA is also oxidized to 3-oxo-LCA, or reabsorbed to the hepatocytes and converted into LCA-3-S in the liver. After conjugation, BAs are again excreted into the bile duct, completing the enterohepatic circulation. In the study, we explored that the sulfate of LCA, LCA-3-S, could bind to RORγt resulting in selectively inhibitory effect on Th17 cell differentiation, which might contribute to the prevention of cholestatic liver diseases. c‐Rel‐dependent monocytes are potent immune suppressor cells in cancer Ting Li, Mayassa J. Bou-Dargham, Norman Fultang, Xinyuan Li, Warren S. Pear, Honghong Sun, Youhai H. Chen
Pages: 845-859 | First Published: 13 June 2022 Clinical utility of heparin‐binding protein as an acute‐phase inflammatory marker in interstitial lung disease Mingshan Xue, Teng Zhang, Runpei Lin, Yifeng Zeng, Zhangkai Jason Cheng, Ning Li, Peiyan Zheng, Huimin Huang, Xiaohua Douglas Zhang, Hongman Wang, Baoqing Sun
Pages: 861-873 | First Published: 14 February 2022 Acteoside promotes B cell‐derived IL‐10 production and ameliorates autoimmunity Meiling Wu, Sulan Yu, Yacun Chen, Wei Meng, Haiyong Chen, Jing He, Jiangang Shen, Xiang Lin
Pages: 875-885 | First Published: 31 May 2022 Pan‐cancer analysis of GALNTs expression identifies a prognostic of GALNTs feature in low grade glioma Chengzhou Mao, Shi-Min Zhuang, Zijin Xia, Zhi-Wen Xiao, Chun-Xia Huang, Qiang Su, Jun Chen, Jing Liao
Pages: 887-899 | First Published: 24 January 2022 CAR NK‐92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo Manting Liu, Wensou Huang, Yongjian Guo, Yubo Zhou, Cheng Zhi, Jingwu Chen, Junping Li, Jinping He, Hui Lian, Jingwen Zhou, Xiaodie Ye, Yuling Hu, Hong Hu, Zhaoyuan Liu, Jingjun Huang, Liteng Lin, Mingyue Cai, Xiaobin Wang, Jingzhen Huang, Zhenfeng Zhang, Kangshun Zhu, Qi Zhao, Bihui Cao
Pages: 901-911 | First Published: 28 January 2022 Tumor‐intrinsic CD21 expression impacts the response of B‐cell malignancy cells to CD19‐CAR‐T cells Dan Li, Qiongyu Xu, Yutian Hu, Wenbing Wang, Shufeng Xie, Chunjun Zhao, Han Liu
Pages: 913-918 | First Published: 25 March 2022 Anticancer effects of disulfiram in T‐cell malignancies through NPL4‐mediated ubiquitin–proteasome pathway Cunte Chen, Dingrui Nie, Youxue Huang, Xibao Yu, Zheng Chen, Mengjun Zhong, Xin Liu, Xianfeng Wang, Songnan Sui, Zhuandi Liu, Jiaxiong Tan, Zhi Yu, Yangqiu Li, Chengwu Zeng
Pages: 919-929 | First Published: 01 April 2022 Dynamic change of circulating innate and adaptive lymphocytes subtypes during a cascade of gastric lesions Weiwei Fu, Wenyan Wang, Jing zhang, Yang Zhao, Keyan Chen, Ye Wang, Jing Zhang, Ying Xiong, Xiaohuan Guo, Shigang Ding
Pages: 931-938 | First Published: 03 June 2022 ERRATUM Free Access
ErratumPages: 939-940 | First Published: 30 September 2022 This article is a correction. |